Mes sa cell line

Manufactured by American Type Culture Collection

Sourced in United States

The MES-SA cell line is a human uterine sarcoma cell line derived from a malignant tumor. It is a well-characterized model system commonly used in cancer research and drug development studies.

Automatically generated - may contain errors

Lab products found in correlation

Dl sulforaphane, by Merck Group (1 mentions) Sk ut1 cell line, by American Type Culture Collection (1 mentions) Tucidinostat, by Selleck Chemicals (1 mentions) Cell titer glo cell viability detection reagent, by Promega (1 mentions) Mrc5 cell, by American Type Culture Collection (1 mentions) Fetal calf serum fbs, by Thermo Fisher Scientific (1 mentions) Dimethyl sulfoxide (dmso), by Merck Group (1 mentions) Pancreatin, by Merck Group (1 mentions)

Spelling variants of this product

MES-SA (25 citations)

2 protocols using mes sa cell line

Evaluating Effects of HDAC Inhibitors on Leiomyoma Cells

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

The source and culture condition of human leiomyoma cell line (HuLM), uterine smooth muscle (UTSM) cell line, SK-UT1 cell line (ATCC, Manassas, VA, USA), and MES-SA cell line (ATCC, Manassas, VA, USA) were described previously [27 (link)].
Class I HDAC inhibitor Tucidinostat was purchased from Selleck Chemical (Cat# S8567, Houston, TX, USA). DL-sulforaphane was purchased from Sigma-Aldrich (Cat# S4441, Saint Louis, MO, USA). The range of doses tested was 1–25 µM.

Yang Q., Falahati A., Khosh A., Mohammed H., Kang W., Corachán A., Bariani M.V., Boyer T.G, & Al-Hendy A. (2022). Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells, 11(23), 3801.

+ Open protocol

+ Expand

Evaluation of Compound Activity against Multi-Drug Resistant Tumor Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 22

The activity of example compounds to multi-drug resistant tumor cell line MES-SA was evaluated.

Experimental materials: DMEM high-glucose cell culture media (Hyclone Company), fetal calf serum (FBS) (Gibco Company), penicillin and streptomycin were purchased from North China Pharmaceutical Co., Ltd, phosphate buffer saline (PBS) was purchased from Gibco Company, Cell Titer-Glo® cell viability detection reagent was purchased from Promega Company, pancreatin and dimethylsulfoxide (DMSO) were products of Sigma Company. MES-SA cell line (human uterine sarcoma cell line) was purchased from ATCC. MRC5 cell (human embryonic lung fibroblast) was purchased from ATCC.

US10160767B2. Rapamycin derivative, and a preparation method, pharmaceutical composition and use thereof (2018-12-25). Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China [CN]. Inventors: Wu Zhong [CN], Song Li [CN], Shuang Cao [CN], Ruiyuan Cao [CN], Junhai Xiao [CN], Xinbo Zhou [CN], Xingzhou Li [CN].

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!